French Body Favors Pharmacy Substitution For Biosimilars

But Move Is Not Supported By Wider European Off-Patent Industry

 
• By David Wallace
  
France
Mixed industry views over pharmacy-level substitution for biosimilars in France • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products